Pretransplant HbA1c Is a Useful Predictor for the Development of New-Onset Diabetes in Renal Transplant Recipients Receiving No or Low-Dose Erythropoietin

Table 2

Risk factors for NODAT^a: univariate and multivariate analyses.

Variable	Univariate analysis			Multivariate analysis
	OR^b	95% CI^c	value	OR	95% CI	value
Recipient age [y]	1.05	1.02–1.12	<0.005	1.06	1.01–1.12	<0.05
Recipient gender	4.45	1.17–29.2	<0.05	4.10	0.99–28.5	0.05
Donor age [y]	0.98	0.93–1.03	0.39
Pretransplant BMI^d	0.98	0.83–1.17	0.95
FPG^e [mg/dL]	1.04	0.98–1.10	0.23
HbA1c [%]	3.99	1.34–12.8	<0.05	3.09	0.90–11.1	0.07
Dialysis period [mo]	1.01	0.99–1.02	0.26

^aNew-onset diabetes after transplantation.
^bOdds ratio.
^c95% confidence interval.
^dBody mass index [kg/m²].
^eFasting plasma glucose.